Is Abacavir Sulfate Injection (Ziagen) in shortage?
Abacavir Sulfate Injection is listed by FDA as being discontinued by at least one maker (updated Nov 16, 2026).
Every listed package
FDA tracks shortages per package. What each maker reports, most recently updated first:
- Ziagen, Injection, 20 mg/1 mL (NDC 49702-222-48)
The anticipated date that ViiV will cease distribution of the product is approximately May 14, 2027.
Maker contact: 877-844-8872
FDA recalls of Abacavir Sulfate
Recalls can cause or worsen a shortage. These FDA drug recalls share an active ingredient with Abacavir Sulfate Injection:
Abacavir Sulfate Injection shortage questions
Is Abacavir Sulfate Injection (Ziagen) in shortage?
Abacavir Sulfate Injection is listed by FDA as being discontinued by at least one maker (updated Nov 16, 2026).
What should I do if I can’t get Abacavir Sulfate Injection?
Don’t stop or ration it on your own. Ask your pharmacist whether another strength, package size or maker is in stock, and ask your prescriber about an alternative if none is.
Source: FDA Drug Shortages Database via openFDA. FDA notes that openFDA data is unvalidated and should not be used to make decisions about medical care; ask your pharmacist or prescriber before changing any medication. FDA Drug Shortages Database.